Navigation Links
Many smokers fail to quit after cancer diagnosis

A new report says despite a growing body of evidence that continued smoking after a cancer diagnosis has substantial adverse effects on treatment effectiveness, overall survival, risk of other cancers, and quality of life, up to one-half of cancer patients who smoke continue to do so or relapse after trying to quit.

The report, published in the January 1, 2006 issue of CANCER, a peer-reviewed journal of the American Cancer Society, says smoking cessation is an underutilized tool in cancer management and that healthcare providers often fail to advise smokers to quit.

The health risks of smoking are well understood. Smoking is linked to many primary diseases, such as cancer and respiratory diseases. In patients diagnosed with cancer, smoking is also associated with poor treatment outcomes, according to recent investigations. Despite these risks, up to half of smokers with cancer continue to smoke or relapse. Treatment for this addiction has largely been focused on healthy smokers and is critically dependent on smoker motivation. The diagnosis of cancer, according to research, is a strong motivator for many smokers and thus, provides a window of opportunity to begin treatment for smoking addiction.

Led by Ellen R. Gritz, Ph.D., of The University of Texas M. D. Anderson Cancer Center in Houston, researchers reviewed the scientific literature to provide a comprehensive overview of smoking cessation and cancer, in particular, guidelines and evidence-based treatment for smoking addiction.

They found that the literature provides ample evidence that patients who quit smoking around the time of diagnosis have improved disease outcomes compared to those who continue to smoke. The efficacy of cancer treatments may be reduced in continuing smokers, side effects of treatment may be exacerbated, and survival rates are lower. Quality of life (QOL) is also better in nonsmokers. For example, multiple studies found that compared to nonsmokers, current
'"/>

Source:John Wiley & Sons, Inc.


Page: 1 2

Related biology news :

1. New MRI technique shows emphysema in asymptomatic smokers
2. Successful lung cancer surgery not enough to break nicotine dependence in many smokers
3. PET imaging shows young smokers quick benefit of quitting
4. Indicators for risk of heart disease are higher in passive smokers
5. Better health twice as likely for nonsmokers who live and work with smoking restrictions
6. Mouse brain cells rapidly recover after Alzheimers plaques are cleared
7. Does vitamin C help prevent or treat the common cold? Maybe not, after all.
8. Stem cell treatment improves mobility after spinal cord injury
9. Bad aftertaste? New sensory on/off switch may cure bane of artificial sweetener search
10. New type of rejection blocker protects kidneys after transplant
11. Hurricane aftermath: Infectious disease threats from common, not exotic, diseases
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Many smokers fail quit after cancer diagnosis

(Date:3/12/2015)... VIEW, Calif. , March 12, 2015 /PRNewswire/ ... with Complimentary Registration here: http://bit.ly/1G7Os0L . SPEAKERS: ... Manager Aravind SeshagiriPhoto - http://photos.prnewswire.com/prnh/20150311/181111 ... in order to compete in several different markets ... market is currently witnessing an uptrend. ...
(Date:3/10/2015)... March 10, 2015   Tute Genomics , pioneer ... selected by next-generation sequencing company PrimBio Research Institute ... and targeted gene panel interpretation. PrimBio, a ... the most current technologies to support the work of ... company offers two types of exome sequencing services: 1) ...
(Date:3/2/2015)... JOSE, Calif. , March 2, 2015 /PRNewswire/ ... the leading developer of human interface solutions, today ... technology that is designed to enable rapid and ... Natural ID™ module for gaming is a turnkey ... ODMs the ability to quickly integrate fingerprint ID ...
Breaking Biology News(10 mins):Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 2Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 3PrimBio Research Selects Tute as Whole Exome Analysis Provider, Creating Integrated, End-to-End Solution for Next-Generation Sequencing & Data Analysis 2PrimBio Research Selects Tute as Whole Exome Analysis Provider, Creating Integrated, End-to-End Solution for Next-Generation Sequencing & Data Analysis 3Synaptics Unveils New Fingerprint ID Solution for Gamers 2Synaptics Unveils New Fingerprint ID Solution for Gamers 3
... vegetative cover, strong winds, dry, non-cohesive sandy soils, ... resources of Abu Dhabi Emirate in the United ... stresses, including wind erosion, salinization, waterlogging, landfilling, and ... Dhabi Emirate, land degradation is a matter of ...
... have found a way to save time, money and ... shed light on the biological processes associated with all ... genetics, and postdoctoral associate Matthew C. Hale have provided ... necessary with recent advances in DNA sequencing technology. Instead, ...
... Pfizer Inc., a major biopharmaceutical company, and the Wisconsin ... licensing organization for the University of Wisconsin-Madison, announced May ... embryonic stem (hES) cell patents for the development of ... the rights to work with hES cells for drug ...
Cached Biology News:Wind, salt and water are leading indicators of land degradation in Abu Dhabi 2Random picks better than complicated process in gene identification 2WARF signs license agreement with Pfizer for human embryonic stem cells 2
(Date:3/26/2015)... 2015 PRC Clinical, a Silicon-Valley based ... management and executive appointments effective immediately. , Mike Catelani ... and member of the Board of Directors. Daniel Head ... Sue Dowden will assume the position of Senior Director ... Operations Officer (COO), has been appointed to the position ...
(Date:3/26/2015)... CINCINNATI , March 26, 2015 ... NASDAQ: SHPG ) and Cincinnati Children,s Hospital ... collaboration for rare diseases. The goal of the collaboration ... treat rare diseases with high unmet medical need ... Children,s research expertise. As a nationally ranked hospital, ...
(Date:3/26/2015)... "In America," the popular news television program that airs ... by legendary film actor James Earl Jones, has announced that ... segment. , Botany is commonly described as the scientific ... a bit more complicated than that. Scientists and other professionals ... from the smallest bacteria known to man to the largest ...
(Date:3/25/2015)... 2015 Agnition announced today that it ... Farmer, airing for the first time at 7:30 a.m. ... Farmer will explore the extremely important role soil microbes ... a patented Microbial Catalystâ„¢ technology that enhances soil and ... segment will air again on April 28. , A ...
Breaking Biology Technology:PRC Clinical Announces Key Management Appointments and Launches East Coast Operations 2PRC Clinical Announces Key Management Appointments and Launches East Coast Operations 3Shire and Cincinnati Children's Establish Rare Disease Research Collaboration 2Shire and Cincinnati Children's Establish Rare Disease Research Collaboration 3Shire and Cincinnati Children's Establish Rare Disease Research Collaboration 4Shire and Cincinnati Children's Establish Rare Disease Research Collaboration 5Agnition to be Featured In Upcoming Episode of American Farmer on RFD-TV 2
... May 7 Nile Therapeutics, Inc. (Nasdaq: NLTX ), ... failure patients, today announced that it has completed the dose escalation ... with acute decompensated heart failure.  Nile had previously announced that the ... proceeding to larger Phase II studies. , ...
... May 7 Cardium Therapeutics (NYSE Amex: CXM ) has been invited ... held May 10-12, 2010 at the Palace Hotel in San Francisco . ... (Logo: http://www.newscom.com/cgi-bin/prnh/20051018/CARDIUMLOGO ) , ... Cardium,s Chairman and Chief Executive Officer, Christopher J. Reinhard is presenting on ...
... ... breakthrough botanical anti-aging skin care ingredient. Unigen® has entered into multiple global license ... of quality skin care, makeup, fragrance and hair care products. , ... (PRWEB) May 7, 2010 -- ...
Cached Biology Technology:Nile Therapeutics Completes Dose Escalation in Ongoing Phase II Study 2Nile Therapeutics Completes Dose Escalation in Ongoing Phase II Study 3Cardium to Present at MDB Capital Group's 2010 Bright Lights Conference 2Cardium to Present at MDB Capital Group's 2010 Bright Lights Conference 3Unigen Announces the Launch of Nivitol™ - Powerful New Anti-Aging Skin Care Ingredient 2Unigen Announces the Launch of Nivitol™ - Powerful New Anti-Aging Skin Care Ingredient 3
Mouse monoclonal [6E10] to LAP2 ( Abpromise for all tested applications). entrezGeneID: 7112 SwissProtID: P42166...
...
Anti-Human Factor XI Purified (Polyclonal) (sheep IgG)...
Rabbit polyclonal to Wilms Tumor Protein ( Abpromise for all tested applications). entrezGeneID: 7490 SwissProtID: P19544...
Biology Products: